Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:2666-2670
Published online before print October 14, 2004, doi: 10.1161/01.STR.0000144052.10644.ed
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/11_suppl_1/2666    most recent
01.STR.0000144052.10644.edv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinstein, P. R.
Right arrow Articles by Sharp, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinstein, P. R.
Right arrow Articles by Sharp, F. R.
Related Collections
Right arrow Acute coronary syndromes

(Stroke. 2004;35:2666.)
© 2004 American Heart Association, Inc.


Articles

Molecular Identification of the Ischemic Penumbra

Philip R. Weinstein, MD; Shwuhuey Hong, BA BS Frank R. Sharp, MD

From the Department of Neurology Surgery (P.R.W., S.H.), San Francisco Veterans Affairs Medical Center and University of California, San Francisco, Calif; and the Department of Neurology (F.R.S.), University of California, Davis, Calif.

Correspondence to Dr Philip R. Weinstein, Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, M 779, San Francisco, CA 94143. E-mail weinsteinp{at}neurosurg.ucsf.edu

Review of results of experimental and clinical studies indicates that the penumbra of physiologically impaired but potentially salvageable tissue surrounding the central core of focal cerebral ischemia that develops shortly after onset of major conducting vessel occlusion is complex and dynamic with severity and duration thresholds for hypoxic stress and injury that are specific to tissue site, cell type, molecular pathway or gene expression investigated and efficiency of collateral or residual flow and reperfusion. Imaging methods that have been utilized in vivo to identify penumbra and predict response to reperfusion and other protective therapies include magnetic resonance spectroscopy, diffusion- and perfusion-MRI as well as positron emission tomography. However, resolution of focal lesions characterized by lactic acidosis or cellular edema does not predict tissue survival, and imaging thresholds for resuscitation after reperfusion have not been determined experimentally. HSP-70 stress protein induction represents an endogenous protective mechanism that occurs in penumbra but not core neurones. A robust protective effect has been demonstrated during focal ischemia in transgenic mice overexpressing HSP-70 perhaps by suppressing early cytochrome c release. Delayed manganese mediated striatal neurodegeneration can be detected with T1 MRI after brief episodes of transient focal ischemia. Future studies may define endogenous cytotoxic and cytoprotective molecular penumbras that can be exploited to improve outcome after temporary focal ischemia.


Key Words: brain edema • blood flow • energy metabolism • magnetic resonance imaging • protein synthesis • stroke, ischemic